UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore which index funds have low turnover and how this characteristic can reduce tax drag, improving after-tax results for long-term investing.
27,549 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Gas prices are climbing despite the U.S. being the world's leading producer of oil. Industry officials point to refin...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
Bitcoin surged above $80,000 as ceasefire headlines circulated, signaling renewed risk appetite in crypto markets. Th...
In a crowded AI field, a defense-focused player shows a different kind of edge: secured access, trusted relationships...
As mid-2026 approaches, a handful of large-cap cryptos trade below their 2025 highs even as networks hit record activ...
A practical, reader-friendly guide to interpreting Xunlei's Q1 2026 earnings. Learn what to watch, how to model resul...
Zcash has finalized the Ironwood upgrade to patch a vulnerability in the Orchard pool, with activation targeted for l...
Wallet V introduces a public performance benchmark for AI trading agents on Hyperliquid and Aster, delivering transpa...
When a memory stock tumbles, it signals more than a one-day drop. This article dissects the drivers behind micron sto...
A caller with dual debt asks for a plan to tackle an $18,000 co-signed card while trimming his own balance. An advise...
This week brought a burst of excitement around Criteo as takeover chatter swirled and the stock jumped. We break down...